AMZN
Amazon.com, Inc.
AMZN's fundamentals are mixed: revenue grew 15%, but free cash flow turned negative. Its PE of 22x looks cheaper than it really is, because one-off gains boosted its recent earnings. Analysts expect strong earnings growth.
BIRD
Allbirds, Inc.
There isn't enough reported data to score BIRD yet.
AMZN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Weak | |
| Healthy |
AMZN's revenue, profitability and balance sheet are currently healthy, but its cash flow is weak.
BIRD Fundamentals
| Metric | Status |
|---|---|
| Weak | |
| Weak | |
| Under pressure | |
| Unavailable |
BIRD's revenue, profitability and cash flow are currently under pressure. There isn't enough data to rate its balance sheet.
AMZN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 22x | $267 | — |
| Forward | 27x | $267 | — |
| Cheap | 34x | $415 | +55% |
| Fair | 60x | $745 | +179% |
| Expensive | 102x | $1,262 | +372% |
Historical ranges are pointers, not guarantees.
AMZN's PE is in its cheap range at 22x, but its recent earnings include one-off gains. On analysts' estimates for next year's earnings, today's price would be 27x.
BIRD PE Valuation
BIRD has no meaningful PE right now: it lost money over the past year.
AMZN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong growth | |
| Growth | |
| Improving | |
| Moderate | |
| Moderate |
Analysts expect earnings and revenue growth for AMZN, with profitability improving.
BIRD Forward outlook
There aren't enough analyst estimates for BIRD to show an outlook.
AMZN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.87 | -20% |
| Q3 2026 | $12.37 | +75% |
| Q2 2026 | $12.43 | +89% |
| Q1 2026 | $8.36 | +36% |
| Q4 2025 | $7.17 | +30% |
| Q3 2025 | $7.08 | +52% |
| Q2 2025 | $6.56 | +57% |
| Q1 2025 | $6.14 | +72% |
| Q4 2024 | $5.53 | +91% |
AMZN has the edge over BIRD on earnings quality, reporting a profit while its opponent remains loss making.
BIRD Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$8.98 | +$1.54 |
| Q1 2026 | -$9.11 | +$1.89 |
| Q4 2025 | -$9.47 | +$2.40 |
| Q3 2025 | -$10.33 | +$5.95 |
| Q2 2025 | -$10.52 | +$7.28 |
| Q1 2025 | -$11.00 | +$8.20 |
| Q4 2024 | -$11.87 | +$8.33 |
| Q3 2024 | -$16.28 | -$0.48 |
BIRD is still losing money, but far less than before: $8.98 per share over the past year, against $20.20 at its worst in late 2023.
AMZN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $201.9B | +12% |
| Q2 2026 | $200.6B | +20% |
| Q1 2026 | $181.5B | +17% |
| Q4 2025 | $213.4B | +14% |
| Q3 2025 | $180.2B | +13% |
| Q2 2025 | $167.7B | +13% |
| Q1 2025 | $155.7B | +8.6% |
| Q4 2024 | $187.8B | +10% |
AMZN has the edge over BIRD on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | +4.2 points |
| Q2 2026 | 14% | +2.3 points |
| Q1 2026 | 13% | +1.3 points |
| Q4 2025 | 12% | +0.4 points |
| Q3 2025 | 9.7% | -1.3 points |
| Q2 2025 | 11% | +1.5 points |
| Q1 2025 | 12% | +1.1 points |
| Q4 2024 | 11% | +3.5 points |
AMZN has the edge over BIRD on profitability, with a higher operating margin.
BIRD Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $2.8M | -93% |
| Q1 2026 | $22.3M | -31% |
| Q4 2025 | $47.7M | -15% |
| Q3 2025 | $33M | -23% |
| Q2 2025 | $39.7M | -23% |
| Q1 2025 | $32.1M | -18% |
| Q4 2024 | $55.9M | -22% |
| Q3 2024 | $43M | -25% |
BIRD's revenue has slid since its 2021 peak: $3M last quarter, down 93% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -388% | -346 points |
| Q1 2026 | -99% | -28 points |
| Q4 2025 | -43% | +2.7 points |
| Q3 2025 | -60% | -9.6 points |
| Q2 2025 | -42% | -2.5 points |
| Q1 2025 | -71% | +4.7 points |
| Q4 2024 | -46% | +34 points |
| Q3 2024 | -51% | +1.9 points |
BIRD's operating margin was −388% last quarter, down 346 points from the same quarter a year ago, near the bottom of its range since 2020.
AMZN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$34.8B | -8202% |
| Q2 2026 | -$8.8B | -2757% |
| Q1 2026 | -$18.2B | -$10.2B |
| Q4 2025 | $14.9B | -16% |
| Q3 2025 | $430M | -87% |
| Q2 2025 | $332M | -96% |
| Q1 2025 | -$8B | -297% |
| Q4 2024 | $17.8B | -36% |
AMZN's free cash flow was −$46.9B over the past year, against $10.6B the year before.
BIRD Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $2.1M | +$11.5M |
| Q1 2026 | -$12.1M | +$16.4M |
| Q4 2025 | -$4.1M | +$7.7M |
| Q3 2025 | -$16.1M | -$4.3M |
| Q2 2025 | -$9.4M | +$7.5M |
| Q1 2025 | -$28.5M | -$1.2M |
| Q4 2024 | -$11.9M | -$5.9M |
| Q3 2024 | -$11.9M | -$4.4M |
BIRD has the edge over AMZN on cash flow, with more consistent year-over-year improvement.
AMZN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +26M shares |
| 1 year | +0.8% | +84M shares |
| 3 years | +3.5% | +371M shares |
| 5 years | +6.1% | +629M shares |
| Available history | +8.2% | +829M shares |
AMZN has the edge over BIRD on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | $3.3B |
BIRD Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +4.9% | +428K shares |
| 1 year | +13% | +1.1M shares |
| 3 years | +22% | +1.6M shares |
| 5 years | +44% | +2.8M shares |
BIRD has 9M diluted shares, up 13% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2021 | — |
| Q1 2021 | — |
| Q4 2020 | — |
| Q3 2020 | — |
AMZN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.3x | Very low |
| Q1 2026 | 0.1x | Very low |
| Q4 2025 | -0.1x | Net Cash |
| Q3 2025 | -0.1x | Net Cash |
| Q2 2025 | -0.0x | Net Cash |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | -0.2x | Net Cash |
AMZN's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago.
BIRD Net Leverage
BIRD's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
AMZN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.1 | Neutral |
| Stochastic | 50.0 | Neutral |
AMZN's weekly RSI is 57 (neutral) and its Stochastic is 50 (neutral).
BIRD Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 36.3 | Neutral |
| Stochastic | 1.2 | Oversold |
BIRD's weekly RSI is 36 (neutral) and its Stochastic is 1 (oversold).
AMZN PE vs Consumer Cyclical Sector
| Metric | AMZN | Sector median | Relative |
|---|---|---|---|
| PE | 22x | 18x | 20% above |
| PE % | 4 | 47 | 43 pts below |
AMZN is trading at 22x earnings, a 20% premium to the Consumer Cyclical sector's median of 18x, though its recent earnings include one-off gains.
BIRD PE vs Consumer Cyclical Sector
BIRD has no meaningful PE right now: it lost money over the past year.
AMZN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $253.6 | 5.5% above |
| 20 week MA | $254.9 | 4.9% above |
| 50 week MA | $242.5 | 10% above |
| 100 week MA | $229.6 | 17% above |
| 200 week MA | $191.4 | 40% above |
AMZN has the edge over BIRD on trend strength, trading above more of its moving averages.
BIRD Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $2.21 | 50% below |
| 20 week MA | $2.47 | 55% below |
| 50 week MA | $3.54 | 69% below |
| 100 week MA | $5.28 | 79% below |
| 200 week MA | $13.0 | 91% below |
BIRD is in a downtrend: it's below all five of its weekly moving averages, and 91% below its 200-week average.
AMZN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $93.5 | $158.6 | +70% |
| 2021 | $158.6 | $171.1 | +7.8% |
| 2022 | $171.1 | $85.3 | -50% |
| 2023 | $85.3 | $151.9 | +78% |
| 2024 | $151.9 | $223.8 | +47% |
| 2025 | $223.8 | $232.5 | +3.9% |
| 2026 YTD | $232.5 | $267.4 | +15% |
AMZN has the edge over BIRD on returns for 2026, with the stronger performance.
BIRD Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $520.6 | $355.0 | -32% |
| 2022 | $355.0 | $47.8 | -87% |
| 2023 | $47.8 | $24.6 | -49% |
| 2024 | $24.6 | $7.39 | -70% |
| 2025 | $7.39 | $4.05 | -45% |
| 2026 YTD | $4.05 | $1.11 | -73% |
BIRD has finished every year since 2021 lower, and it's down 73% so far in 2026.